Recent CANF Stock Price | CANF Stock Predictions | |
$2.13 | +604.23% |
$15.00 |
Recent CANF Analyst Ratings Breakdown, Making CANF Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 1 | 1 | 2 | 2 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.0 | 1.0 | 1.0 | 1.0 |
For the CANF stock predictions from the analysts covering Can-Fite Biopharma Ltd., we have collected all of the individual CANF stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 2 different analysts covering CANF (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since CANF stock predictions may vary widely, another useful metric to consider is the median CANF stock prediction, which represents the price at which half of the analysts
made CANF stock predictions that were higher and half made CANF stock predictions that were lower. This makes for a different take on the CANF stock predictions out there, as compared to average or mean.
And that median across all the individual CANF stock predictions was: $15.0 as of 2024-05-14.
The very highest of the CANF stock predictions for one year price target was $18.0, while the very lowest of the CANF stock predictions in the analyst group was
$12.0 (with a standard deviation of $4.242). Get the latest Zacks research report on CANF — FREE
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
EVLO Stock Predictions
WDR Stock Predictions
AUPH Stock Predictions
IQ Stock Predictions
GBLI Stock Predictions
ALV Stock Predictions
MUSA Stock Predictions
NMFC Stock Predictions
MXL Stock Predictions
|
|
Strong Buy (4.00 out of 4) 96th percentile
(ranked higher than approx. 96% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |